1 / 7

Geriatric Medicines Market

Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.

Ronald15
Download Presentation

Geriatric Medicines Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Geriatric Medicines Market Market Size Worth $1,157.34 Billion By 2026

  2. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 “As per Polaris Market Research report, Geriatric Medicines Market is attending major innovations & transformations and is projected to reach $1,157.34 Billion By 2026 during the conjecture period 2018 to 2026.” The global Geriatric Medicines Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Geriatric Medicines Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2026. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Geriatric Medicines Market Report Scope: The global Geriatric Medicines Market is segmented ByTherapeutic Category, By Therapeutic Conditions, By Origin, By Regions. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Geriatric Medicines Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Geriatric Medicines Market growth during the forecast period from 2018-2026. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 By Therapeutic Category By Therapeutic Conditions By Regions • • • • • • • • •Cardiovascular •North America - U.S., Canada Analgesics Antihypertensive Statins Antidiabetics Proton Pump Inhibitor Anticoagulant Antipsychotic Antidepressant •Arthritis •Europe - Germany, UK, France, Italy, Russia •Neurological •Asia-Pacific - China, India, Japan, Australia •Cancer •Latin America - Brazil, Mexico •Osteoporosis •Middle East & Africa •Respiratory ➢COVID-19 Impact Analysis for Geriatric Medicines Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Geriatric Medicines Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Geriatric Medicines Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Geriatric Medicines Market Analysis: https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market - 3 -

  4. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines- Request for sample: market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-aways 1.5.Stakeholders 2.Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Geriatric Medicines Market Insights 3.1.Geriatric Medicines – Industry snapshot 3.2.Geriatric Medicines - Ecosystem analysis 3.3.Geriatric Medicines Market dynamics 3.3.1.Geriatric Medicines – Market Forces 3.3.1.1. Geriatric Medicines Market driver analysis 3.3.1.2. Geriatric Medicines Market restraint/challenges analysis 3.3.1.3. Geriatric Medicines Market opportunity analysis 3.4.Industry analysis - Porter's five force 3.4.1.Bargaining power of supplier 3.4.2.Bargaining power of buyer 3.4.3.Threat of substitute 3.4.4.Threat of new entrant 3.4.5.Degree of competition 3.5.Geriatric Medicines Market PEST analysis, 2017 3.5.1.Geriatric Medicines Industry trends 3.5.2.Competitive Ranking Analysis 4.Geriatric Medicines Market Size and Forecast by Therapeutic Category 4.1.Key findings 4.2.Analgesics 4.2.1.Global market estimates and forecasts, 2017 – 2026 4.3.Antihypertensives 4.3.1.Global market estimates and forecasts, 2017 – 2026 4.4.Statins 4.4.1.Global market estimates and forecasts, 2017 – 2026 4.5.Antidiabetics - 4 -

  5. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 4.5.1.Global market estimates and forecasts, 2017 – 2026 4.6.Proton Pump Inhibitor 4.6.1.Global market estimates and forecasts, 2017 – 2026 4.7.Anticoagulant 4.7.1.Global market estimates and forecasts, 2017 – 2026 4.8.Antipsychotic 4.8.1.Global market estimates and forecasts, 2017 – 2026 4.9.Antidepressant 4.9.1.Global market estimates and forecasts, 2017 – 2026 5.Geriatric Medicines Market Size and Forecast by Therapeutic Condition 5.1.Key findings 5.2.Cardiovascular 5.2.1.Global market estimates and forecasts, 2017 - 2026 5.3.Arthritis 5.3.1.Global market estimates and forecasts, 2017 – 2026 5.4.Neurological 5.4.1.Global market estimates and forecasts, 2017 – 2026 5.5.Cancer 5.5.1.Global market estimates and forecasts, 2017 - 2026 5.6.Osteoporosis 5.6.1.Global market estimates and forecasts, 2017 – 2026 5.7.Respiratory 5.7.1.Global market estimates and forecasts, 2017 – 2026 6.Geriatric Medicines Market Size and Forecast by Regions 6.1.Key findings 6.2.North America 6.2.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.2.3.U.S. 6.2.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.2.4.Canada 6.2.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.Europe 6.3.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.3.Germany 6.3.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.4.UK 6.3.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.5.France 6.3.5.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.5.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.6.Italy 6.3.6.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.6.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.Asia Pacific - 5 -

  6. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 6.4.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.3.China 6.4.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.4.India 6.4.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.5.Japan 6.4.5.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.5.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.6.Australia 6.4.6.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.6.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5.Latin America 6.5.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5.3.Brazil 6.5.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5.4.Mexico 6.5.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.6.Middle East & Africa 6.6.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.6.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 7.Company Profiles 7.1.GlaxoSmithKline Plc 7.1.1.Overview 7.1.2.Financials 7.1.3.Product Benchmarking 7.1.4.Recent Developments 7.2.BoehringerIngelheim GmbH 7.2.1.Overview 7.2.2.Financials 7.2.3.Product Benchmarking 7.2.4.Recent Developments 7.3.Novartis AG 7.3.1.Overview 7.3.2.Financials 7.3.3.Product Benchmarking 7.3.4.Recent Developments 7.4.Bristol-Myers Squibb Company 7.4.1.Overview 7.4.2.Financials 7.4.3.Product Benchmarking 7.4.4.Recent Developments 7.5.Pfizer, Inc. 7.5.1.Overview 7.5.2.Financials - 6 -

  7. Geriatric Medicines Market Size Worth $1,157.34 Billion By 2026 7.5.3.Product Benchmarking 7.5.4.Recent Developments 7.6.Eli Lilly and Company 7.6.1.Overview 7.6.2.Financials 7.6.3.Product Benchmarking 7.6.4.Recent Developments 7.7.Abbott Laboratories Inc. 7.7.1.Overview 7.7.2.Financials 7.7.3.Product Benchmarking 7.8.AstraZeneca plc 7.8.1.Overview 7.8.2.Financials 7.8.3.Product Benchmarking 7.8.4.Recent Developments 7.9.Merck & Company Inc. 7.9.1.Overview 7.9.2.Financials 7.9.3.Product Benchmarking 7.9.4.Recent Developments 7.10. Sanofi S.A. 7.10.1.Overview 7.10.2.Financials 7.10.3.Product Benchmarking 7.10.4.Recent Developments ➢Access Press Release on Geriatric Medicines Market: https://www.polarismarketresearch.com/press-releases/geriatric-medicines-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com - 7 - Official Blog: http://polarismarketresearch.blogspot.com

More Related